Diffuse Large B-cell Lymphoma, c-MYC Positive
1 clinical trials · Condition
◉ Watch Diffuse Large B-cell Lymphoma, c-MYC Positive
| Record | Firm | Date |
|---|---|---|
| Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma (NCT01092182) | National Cancer Institute (NCI) | 2010-03-25 |
Track Diffuse Large B-cell Lymphoma, c-MYC Positive automatically
Every clearance here is in the API, with alerts when new ones post.